Mechanism of action of 2-methoxyestradiol: New developments

Drug Resistance Updates

Volumn 6, Issue 6, 2003, Pages 355-361

  Mooberry, Susan L ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

2 Methoxyestradiol; Angiogenesis; Anti angiogenesis; Antitumor; HIF 1

Indexed keywords

2 METHOXYESTRADIOL; ANGIOGENESIS INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER HORMONE THERAPY; CELL TYPE; CLINICAL TRIAL; DEPOLYMERIZATION; DRUG MECHANISM; HUMAN; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0842269204     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2003.10.001     Document Type: Article

References (40)

1. Attalla, H., Westberg, J.A., Andersson, L.C., Adlercreutz, H., Makela, T.P., 1998. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Biochem. Biophys. Res. Commun. 247, 616-619.
2. Basu, A., Haldar, S., 2003. Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett. 538, 41-47.
3. Broxterman, H.J., Lankelma, J., Hoekman, K., 2003. Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences. Drug Resist. Updat. 6, 111-127.
4. Brueggemeier, R.W., Bhat, A.S., Lovely, C.J., et al., 2001. 2-Methoxy-methylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. J. Steroid Biochem. Mol. Biol. 78, 145-156.
5. Bu, S., Blaukat, A., Fu, X., Heldin, N.E., Landstrom, M., 2002. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett. 531, 141-151.
6. Carothers, A.M., Hughes, S.A., Ortega, D., Bertagnolli, M.M., 2002. 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells. Cancer Lett. 187, 77-86.
7. Chauhan, D., Li, G., Hideshima, T., Podar, K., Mitsiades, C., Mitsiades, N., Munshi, N., Kharbanda, S., Anderson, K.C., 2003. JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J. Biol. Chem. 278, 17593-17596.
8. Cushman, M., He, H.M., Katzenellenbogen, J.A., Lin, C.M., Hamel, E., 1995. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J. Med. Chem. 38, 2041-2049.
9. D'Amato, R.J., Lin, C.M., Flynn, E., Folkman, J., Hamel, E., 1994. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. U.S.A. 91, 3964-3968.
10. Dawling, S., Roodi, N., Parl, F.F., 2003. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res. 63, 3127-3132.
11. Djavaheri-Mergny, M., Wietzerbin, J., Besancon, F., 2003. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 22, 2558-2567.
12. Fotsis, T., Zhang, Y., Pepper, M.S., Adlercreutz, H., Montesano, R., Nawroth, P.P., Schweigerer, L., 1994. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368, 237-239.
13. Fulda, S., Debatin, K.M., 2003. Apoptosis pathways: turned on their heads? Drug Resist. Updat. 6, 1-3.
14. Ghosh, R., Ott, A.M., Seetharam, D., Slaga, T.J., Kumar, A.P., 2003. Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol: therapeutic implications? Melanoma Res. 13, 119-127.
15. Golab, J., Nowis, D., Skrzycki, M., et al., 2003. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J. Biol. Chem. 278, 407-414.
16. Halliwell, B., 2000. A super way to kill cancer cells? Nat. Med. 6, 1105-1106.
17. Huang, P., Feng, L., Oldham, E.A., Keating, M.J., Plunkett, W., 2000. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390-395.
18. Kachadourian, R., Liochev, S.I., Cabelli, D.E., Patel, M.N., Fridovich, I., Day, B.J., 2001. 2-Methoxyestradiol does not inhibit superoxide dismutase. Arch. Biochem. Biophys. 392, 349-353.
19. Kerbel, R., Folkman, J., 2002. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727-739.
20. Kim, P.K.M., Mahidhara, R., Seol, D.W., 2001. The role of caspase-8 in resistance to cancer chemotherapy. Drug Resist. Updat. 4, 293-296.
21. Kumar, A.P., Garcia, G.E., Orsborn, J., Levin, V.A., Slaga, T.J., 2003. 2-Methoxyestradiol interferes with NF kappa B transcriptional activity in primitive neuroectodermal brain tumors: implications for management. Carcinogenesis 24, 209-216.
22. Lakhani, N.J., Sarkar, M.A., Venitz, J., Figg, W.D., 2003. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165-172.
23. LaVallee, T.M., Zhan, X.H., Herbstritt, C.J., Kough, E.C., Green, S.J., Pribluda, V.S., 2002. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 62, 3691-3697.
24. LaVallee, T.M., Zhan, X.H., Johnson, M.S., et al., 2003. 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res. 63, 468-475.
25. Lippert, T.H., Adlercreutz, H., Berger, M.R., Seeger, H., Elger, W., Mueck, A.O., 2003. Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea (MNU)-induced rat mammary carcinoma. J. Steroid Biochem. Mol. Biol. 84, 51-56.
26. Mabjeesh, N.J., Escuin, D., LaVallee, T.M., et al., 2003. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3, 363-375.
27. Miller, K.D., Sweeney, J., Sledge, Jr., G.W., 2001. Redefining the target: chemotherapeutics as antiangiogenics. J. Clin. Oncol. 19, 1195-1206.
28. Pribluda, V.S., Gubish, Jr., E.R., Lavallee, T.M., Treston, A., Swartz, G.M., Green, S.J., 2000. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev. 19, 173-179.
29. Qanungo, S., Basu, A., Das, M., Haldar, S., 2002. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 21, 4149-4157.
30. Ryschich, E., Werner, J., Gebhard, M.M., Klar, E., Schmidt, J., 2003. Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma. Pancreas 26, 166-172.
31. Sattler, M., Quinnan, L.R., Pride, Y.B., et al., 2003. 2-Methoxyestradiol alters cell motility, migration, and adhesion. Blood 102, 289-296.
32. Seegers, J.C., Aveling, M.L., Van Aswegen, C.H., Cross, M., Koch, F., Joubert, W.S., 1989. The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32, 797-809.
33. Semenza, G.L., 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
34. Shimada, K., Nakamura, M., Ishida, E., Kishi, M., Konishi, N., 2003. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24, 1067-1075.
35. Sibonga, J.D., Lotinun, S., Evans, G.L., Pribluda, V.S., Green, S.J., Turner, R.T., 2003. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat. Endocrinology 144, 785-792.
36. Sibonga, J.D., Sommer, U., Turner, R.T., 2002. Evidence that 2-methoxyestradiol suppresses proliferation and accelerates apoptosis in normal rat growth plate chondrocytes. J. Cancer Res. Clin. Oncol. 128, 477-483.
37. Tinley, T.L., Leal, R.M., Randall-Hlubek, D.A., Cessac, J.W., Wilkens, L.R., Rao, P.N., Mooberry, S.L., 2003. Novel 2-methoxyestradiol analogues with antitumor activity. Cancer Res. 63, 1538-1549.
38. Vasilevskaya, I., O'Dwyer, P.J., 2003. Role of Jun and Jun kinase in resistance of cancer cells to therapy. Drug Resist. Updat. 6, 147-156.
39. Yue, T.L., Wang, X., Louden, C.S., Gupta, S., Pillarisetti, K., Gu, J.L., Hart, T.K., Lysko, P.G., Feuerstein, G.Z., 1997. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol. 51, 951-962.
40. Zhou, Y., Hileman, E.O., Plunkett, W., Keating, M.J., Huang, P., 2003. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101, 4098-4104.